Riverview Trust Co raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,121 shares of the healthcare conglomerate’s stock after purchasing an additional 33 shares during the period. Riverview Trust Co’s holdings in UnitedHealth Group were worth $567,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. State Street Corp boosted its holdings in UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares during the last quarter. Geode Capital Management LLC raised its holdings in UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after acquiring an additional 318,039 shares during the last quarter. Franklin Resources Inc. boosted its stake in UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 0.5% in the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock valued at $4,012,218,000 after purchasing an additional 36,394 shares during the period. Finally, Fisher Asset Management LLC increased its holdings in shares of UnitedHealth Group by 7.4% during the 4th quarter. Fisher Asset Management LLC now owns 3,434,467 shares of the healthcare conglomerate’s stock worth $1,737,360,000 after buying an additional 237,300 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on UNH shares. Barclays lowered their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. KeyCorp restated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.
UnitedHealth Group Price Performance
Shares of NYSE UNH opened at $474.95 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock’s 50-day simple moving average is $516.59 and its 200-day simple moving average is $557.04. The firm has a market capitalization of $437.09 billion, a PE ratio of 30.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $5.83 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
Insider Transactions at UnitedHealth Group
In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- The Risks of Owning Bonds
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- 3 Small Caps With Big Return Potential
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.